Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

298.81
+3.001.01%
Post-market: 298.810.00000.00%19:54 EDT
Volume:1.96M
Turnover:582.45M
Market Cap:160.87B
PE:24.43
High:299.37
Open:295.24
Low:293.14
Close:295.81
52wk High:335.88
52wk Low:253.30
Shares:538.36M
Float Shares:536.99M
Volume Ratio:0.92
T/O Rate:0.36%
Dividend:9.26
Dividend Rate:3.10%
EPS(TTM):12.23
EPS(LYR):7.62
ROE:99.14%
ROA:7.51%
PB:21.66
PE(LYR):39.23

Loading ...

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

stock_story_highlight
·
Oct 08

Martin Capital Buys Into Portland General Electric’s Defensive Power Play

Motley Fool
·
Oct 08

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Cencora (COR) and Amgen (AMGN)

TIPRANKS
·
Oct 07

Amgen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Oct 07

Amgen Significantly Cuts Drug Prices Following Trump's Threats

Deep News
·
Oct 07

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock

Motley Fool
·
Oct 07

Amgen Shares Down 1.5% After Co to Sell Cholesterol Drug at 60% Discount to Cash-Paying US Patients

THOMSON REUTERS
·
Oct 07

BUZZ-Amgen stock falls as Repatha gets direct sales price cut

Reuters
·
Oct 07

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan

Motley Fool
·
Oct 06

GoodRx Expands Affordable Access to Cholesterol Drug Repatha

MT Newswires Live
·
Oct 06

Amgen Introduces Direct-to-Patient Access for Repatha in US

MT Newswires Live
·
Oct 06

BRIEF-Amgen Makes Repatha® Available Through Amgennow, A Direct-To-Patient Program In The U.S.

Reuters
·
Oct 06

Amgen Makes Repatha® Available Through Amgennow, a Direct-to-Patient Program in the U.S.

THOMSON REUTERS
·
Oct 06

Amgen: Program Open to All Patients, Including Those Who Are Uninsured or in High-Deductible Health Plans or Prefer to Pay With Cash or Out of Pocket

THOMSON REUTERS
·
Oct 06

Amgen: Repatha to Be Available Through Amgennow at a Monthly Price of $239, Nearly 60% Lower Than Current U.S. List Price

THOMSON REUTERS
·
Oct 06

Amgen to sell cholesterol drug at 60% discount direct to US consumers

Reuters
·
Oct 06

Amgen: Plans to Make Amgennow Accessible via the Trumprx Website

THOMSON REUTERS
·
Oct 06

4 Reasons to Buy Amgen Stock Right Now

Motley Fool
·
Oct 04

Amgen’s Repatha Achieves Landmark Results in Phase 3 VESALIUS-CV Trial, Significantly Reducing Cardiovascular Events in High-Risk Patients Without Prior Heart Attack or Stroke

Reuters
·
Oct 02

Landmark Phase 3 Trial (Vesalius-Cv) Meets Primary Endpoints in a Cardiovascular Primary Prevention Study of 12,000 Patients

THOMSON REUTERS
·
Oct 02